Scoop has an Ethical Paywall
Statement From Johnson & Johnson NZ Regarding Additional Pharmac Funding
Johnson & Johnson welcomes the New Zealand Government’s announcement to dedicate an additional $604m to bring much needed innovative cancer medicines to New Zealand patients.
“There is currently a significant unmet need in a range of cancer treatment options,” Hayden Paul, Commercial Lead, Johnson & Johnson New Zealand said.
“J&J believes this week’s announcement is a positive sign for the thousands of patients who are waiting for access to medicines. We trust the Government will act swiftly to finalise access to these new medicines for cancer treatment.
“New Zealand has long been a challenging environment for medicines access and for medicines businesses. This announcement offers the possibility for increased business confidence and could support increased investment and jobs for New Zealand’s future.”
NZEI Te Riu Roa: School Lunches - Give Schools Option To Use In-School And Community Providers Immediately, Union Says
University of Auckland: Billion-dollar Business Lessons From Kiwi Entrepreneur
NZ Veterinary Association: NZVA Celebrates Welcome Additional Support From Veterinary Nurses
Michael King Writers Centre: New Zealand’s National Writer-Residency Organisation Announces Its 2025 International Residency With Australia
Endometriosis NZ: Desogestrel Funding A Major Boost For Endometriosis Patients
Auckland Festival of Photography: Project Launched To Capture And Diversify Auckland’s Visual Heritage